MUM1/IRF4 immunolabeling of neoplastic Langerhans histiocytes in a putative case of canine Langerhans cell histiocytosis

Vet Clin Pathol. 2023 Dec;52(4):670-675. doi: 10.1111/vcp.13270. Epub 2023 Aug 1.

Abstract

Langerhans cell histiocytosis is a systemic histiocytic proliferative disease with cutaneous manifestations which is well described in human medical literature and has relatively recently been reclassified as a neoplastic disorder. The diagnosis of canine Langerhans cell histiocytosis has been proposed in the veterinary literature to refer to a histiocytic proliferative disease in the dog with clinical and histopathologic features that mirror the human disease. However, reports that invoke this diagnosis are rare and often lack complete diagnostic characterization. This case report presents an extensive diagnostic investigation of a putative case of Langerhans cell histiocytosis in a 3-year-old male castrated Golden Retriever dog, including gross, cytologic, histopathologic, and immunohistochemical findings. Furthermore, we document that canine LCH may have positive immunolabeling for the transcription factor multiple myeloma oncogene 1/interferon regulatory factor 4 (MUM1/IRF4), which is classically used for the diagnosis of canine plasma cell neoplasms.

Keywords: dogs; histiocytic disorders; interferon regulatory factor 4; malignant; pathology; skin diseases.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Dog Diseases* / diagnosis
  • Dog Diseases* / pathology
  • Dogs
  • Histiocytes / metabolism
  • Histiocytes / pathology
  • Histiocytosis, Langerhans-Cell* / diagnosis
  • Histiocytosis, Langerhans-Cell* / pathology
  • Histiocytosis, Langerhans-Cell* / veterinary
  • Humans
  • Interferon Regulatory Factors / metabolism
  • Male
  • Plasmacytoma* / pathology
  • Plasmacytoma* / veterinary

Substances

  • Interferon Regulatory Factors